🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/04/2010 | 35,27 | 35,39 | 35,11 | 35,16 | -0,32% | 0,78% | 11.175.662 |
| 09/04/2010 | 35,11 | 35,54 | 35,10 | 35,28 | +0,52% | 1,28% | 10.552.941 |
| 08/04/2010 | 35,15 | 35,32 | 34,94 | 35,10 | -0,03% | 1,09% | 12.922.154 |
| 07/04/2010 | 35,67 | 35,70 | 34,89 | 35,11 | -1,23% | 2,27% | 19.274.921 |
| 06/04/2010 | 35,81 | 35,81 | 35,47 | 35,54 | -0,37% | 0,96% | 12.864.095 |
| 05/04/2010 | 36,20 | 36,23 | 35,62 | 35,68 | -0,85% | 1,69% | 10.966.796 |
| 01/04/2010 | 35,92 | 36,15 | 35,78 | 35,98 | +0,96% | 1,01% | 10.621.794 |
| 31/03/2010 | 35,77 | 35,87 | 35,36 | 35,64 | -0,82% | 1,41% | 13.588.787 |
| 30/03/2010 | 36,22 | 36,22 | 35,79 | 35,94 | -0,61% | 1,19% | 10.397.313 |
| 29/03/2010 | 35,86 | 36,27 | 35,86 | 36,15 | +1,23% | 1,14% | 11.693.898 |
| 26/03/2010 | 36,09 | 36,20 | 35,64 | 35,72 | -0,93% | 1,56% | 14.149.782 |
| 25/03/2010 | 36,57 | 36,58 | 36,03 | 36,05 | -0,61% | 1,51% | 13.808.029 |
| 24/03/2010 | 36,67 | 36,75 | 36,24 | 36,27 | -1,27% | 1,38% | 12.930.643 |
| 23/03/2010 | 36,80 | 36,98 | 36,50 | 36,74 | +0,52% | 1,30% | 12.927.185 |
| 22/03/2010 | 36,34 | 37,25 | 36,29 | 36,55 | +0,63% | 2,65% | 16.215.914 |
| 19/03/2010 | 36,32 | 37,06 | 36,12 | 36,32 | -1,01% | 2,60% | 32.252.934 |
| 18/03/2010 | 36,33 | 36,70 | 36,15 | 36,69 | +0,97% | 1,52% | 13.097.275 |
| 17/03/2010 | 36,25 | 36,36 | 35,85 | 36,34 | +0,37% | 1,40% | 12.983.986 |
| 16/03/2010 | 36,04 | 36,26 | 35,69 | 36,20 | +0,50% | 1,59% | 19.187.937 |
| 15/03/2010 | 35,34 | 36,07 | 35,31 | 36,02 | +1,59% | 2,16% | 18.251.863 |
| 12/03/2010 | 35,35 | 35,50 | 35,05 | 35,46 | +0,76% | 1,27% | 17.172.738 |
| 11/03/2010 | 34,69 | 35,26 | 34,45 | 35,19 | +0,57% | 2,34% | 16.049.177 |
| 10/03/2010 | 35,26 | 35,38 | 34,83 | 34,99 | -1,00% | 1,57% | 20.357.505 |
| 09/03/2010 | 35,51 | 35,59 | 35,14 | 35,34 | -0,83% | 1,26% | 15.401.198 |
| 08/03/2010 | 35,77 | 35,82 | 35,41 | 35,64 | -0,37% | 1,15% | 12.625.570 |
| 05/03/2010 | 35,52 | 35,84 | 35,24 | 35,77 | +0,94% | 1,69% | 10.342.502 |
| 04/03/2010 | 35,58 | 35,67 | 35,19 | 35,44 | -0,19% | 1,34% | 12.421.839 |
| 03/03/2010 | 35,96 | 36,12 | 35,40 | 35,51 | -0,48% | 1,99% | 13.186.879 |
| 02/03/2010 | 35,86 | 35,96 | 35,61 | 35,68 | +0,32% | 0,98% | 12.842.402 |
| 01/03/2010 | 35,33 | 35,72 | 35,33 | 35,56 | +1,06% | 1,08% | 12.373.107 |